DEGRO guidelines for the radiotherapy of non-malignant disorders M. Heinrich SeegenschmiedtOliver MickeThe German Cooperative Group on Radiotherapy of Benign Diseases (GCG-BD) Original Article 10 March 2015 Pages: 541 - 548
Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer Tamara RumpoldCarola Lütgendorf-CaucigKathrin Kirchheiner Original Article 18 February 2015 Pages: 549 - 556
The mean lung dose (MLD) Thomas HerrmannPeter GeyerSteffen Appold Original Article 13 April 2015 Pages: 557 - 565
High-grade acute organ toxicity and p16INK4A expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma Narges TehranyJulia KitzHendrik A. Wolff Original Article 10 January 2015 Pages: 566 - 572
A feasibility dosimetric study on prostate cancer Carmelo MarinoElena VillaggiPietro Mancosu Original Article 08 March 2015 Pages: 573 - 581
Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer Nathalie RochetKatja LindelJuergen Debus Original Article 19 March 2015 Pages: 582 - 589
Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines Caroline SteenkenJens FleckensteinFrank Anton Giordano Original Article 13 March 2015 Pages: 590 - 596
Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma Matthias UhlThomas WelzelJürgen Debus Original Article 04 March 2015 Pages: 597 - 603
Long-term side effects of radiotherapy for pediatric localized neuroblastoma Anne DucassouMarion GambartOn behalf of the Neuroblastoma study group and radiotherapy group of the French Society of Children with Cancer (SFCE) Original Article 21 April 2015 Pages: 604 - 612
Effekt der additiven Boost-Bestrahlung bei der Radiotherapie nach brusterhaltender Operation des frühen Mammakarzinoms Kirsten EilfJürgen Dunst Literatur kommentiert 12 May 2015 Pages: 613 - 615
Sollte man nach brusterhaltender Therapie bei Frauen über 65 Jahren mit einem frühen Mammakarzinom auf die adjuvante Radiotherapie verzichten? David Krug Literatur kommentiert 07 May 2015 Pages: 616 - 618
Anti-EGFR-Therapie in Kombination mit Radiotherapie für Patienten mit Kopf-Hals-Karzinomen – doch keine therapeutische Revolution Panagiotis Balermpas Literatur kommentiert 05 May 2015 Pages: 619 - 622